Normal Lactic Acid Level Sepsis: Clinical Signs and Implications

Sepsis patients with normal serum lactate levels still face meaningful mortality risk, and a normal reading should never be treated as an all-clear. Data from U.S. and European intensive care units show that patients with normal lactate had a 28-day mortality rate of about 17%, compared with roughly 40% in those with elevated levels. That gap is significant, but 17% is far from trivial. The challenge for clinicians and patients alike is that lactate has become so central to sepsis screening protocols that a normal result can create a false sense of security, delaying the aggressive treatment sepsis demands.

How Often Sepsis Patients Present With Normal Lactate

Lactate above 2 mmol/L is widely used as a red flag in sepsis protocols, but a substantial share of patients with confirmed severe sepsis or septic shock never cross that threshold. In one study screening over 1,000 patients, 338 met criteria for severe sepsis or septic shock and had an initial lactate drawn within 24 hours. Of those, 42% were classified as “nonexpressors” with initial lactate below 2.5 mmol/L.¹ That is not a small minority. Nearly half the patients with clinically serious infections had lactate readings that many triage systems would flag as reassuring.

This creates a real diagnostic blind spot. When emergency departments rely on lactate as a primary screening tool, patients whose bodies respond to infection without a dramatic lactate spike can end up triaged to lower-acuity areas. Research on antibiotic delays has shown that vague presenting symptoms and triage to nonacute areas are independently associated with delays in antibiotic administration, and those delays are associated with worse outcomes.² A patient who “looks okay” and has a normal lactate is exactly the kind of patient who gets a delayed workup.

Why Some Sepsis Patients Do Not Produce Elevated Lactate

The assumption behind lactate-based screening is straightforward: when tissues don’t get enough oxygen, cells switch to a less efficient energy pathway that produces lactate as a byproduct. In sepsis, poor blood flow and low blood pressure starve tissues of oxygen, so lactate rises. But the relationship between infection severity and lactate production is more complicated than that model suggests.

One reason involves the microcirculation, the network of tiny blood vessels where oxygen actually transfers to tissue. Even when overall blood pressure and cardiac output look acceptable, flow through these small vessels can be uneven. Some capillary beds get adequate flow while others are starved. A study linking microcirculatory abnormalities to lactate found that even mildly elevated lactate levels correlated with impaired convective oxygen transport at the microvascular level.³ The flip side of that finding is relevant here: if a patient’s microcirculation happens to hold together better during sepsis, they may not produce much lactate even though they are genuinely infected and at risk of deterioration.

A separate mechanism involves what researchers call cytopathic hypoxia. In this scenario, cells have access to oxygen but cannot use it properly because the internal machinery of the cell, specifically the mitochondria, is damaged by the inflammatory cascade. The result is reduced energy production despite normal or even high oxygen delivery.⁴ If cells are failing to metabolize normally because of mitochondrial dysfunction rather than oxygen deprivation, the classic lactate signal may not fire the same way. The damage is real, but it does not necessarily leave a clear trail in the lactate number.

Medications That Suppress Lactate

One of the more clinically important reasons for a normal lactate in a sick patient is medication use, particularly beta-blockers. These drugs, commonly prescribed for high blood pressure, heart failure, and heart rhythm problems, dampen the body’s stress response. In sepsis, part of the lactate surge comes from a flood of adrenaline driving cells to ramp up their metabolism. Beta-blockers blunt that response.

A study of severely septic patients found that those on long-term beta-blocker therapy had significantly lower blood lactate at presentation, averaging around 3.9 mmol/L compared to 5.6 mmol/L in patients not on beta-blockers. Nearly four times more patients on beta-blockers had normal lactate levels during severe sepsis and septic shock. The study’s authors concluded that using lactate as a triage tool in these patients may underestimate the true severity of the illness.⁵ A separate retrospective analysis found that patients prescribed beta-blockers in the community were significantly less likely to have an initial lactate at or above 4 mmol/L compared to those not on beta-blockers.⁶

The evidence is not perfectly uniform. One emergency department study found no significant effect of long-term beta-blocker therapy on initial venous lactate in patients with suspected sepsis.⁷ The discrepancy may reflect differences in how sick the patients were at enrollment: beta-blockers seem to suppress lactate more dramatically in the sickest patients, where the adrenergic drive is highest. In milder suspected sepsis, the effect may be less noticeable. Either way, the possibility that beta-blockers mask a high lactate is worth knowing about, because millions of people take these medications daily and a falsely reassuring lactate could change how quickly their sepsis is treated.

Mortality Risk When Lactate Stays Normal

Patients with normal lactate do, on average, fare better than those with elevated levels. A study drawing on both U.S. and European ICU cohorts found 28-day mortality of about 17% in the normal-lactate group versus roughly 40% in the high-lactate group, despite the two groups having comparable physiologic profiles by other measures.⁸ That finding underscores a key point: the patients with normal lactate were not less sick by other yardsticks. They had similar organ dysfunction scores and similar clinical presentations. Their lactate just happened not to rise.

An interesting corollary is that among sepsis patients who do have normal lactate, the presence or absence of low blood pressure does not seem to change mortality much. One study found that in sepsis patients with normal lactate, those who were hypotensive at the time of recognition did not have higher ICU or in-hospital mortality than those with normal blood pressure, even though the hypotensive group required vasopressors more often.⁹ What did matter, the authors found, was whether antibiotics were started promptly and whether lactate was measured early.

Conversely, among patients who are not yet hypotensive, a high lactate is a serious warning sign. Research on a classification system grouping infected patients by blood pressure and lactate found that the odds of a normotensive patient decompensating were three to four times higher when lactate was elevated.¹⁰ In other words, lactate is a powerful prognostic tool when it is elevated. The problem is that a normal reading does not provide equivalent reassurance in the opposite direction.

The Concept of Cryptic Shock

When a patient has evidence of tissue underperfusion but their vital signs, including blood pressure, still look acceptable, the condition is sometimes called cryptic shock. In this state, the body is compensating hard enough to keep the numbers looking passable at first glance, but the underlying oxygen delivery is already inadequate. Lactate may or may not be elevated in cryptic shock. The concept highlights the gap between what the body can mask and what standard vital-sign monitoring can detect.¹¹

Markers like blood pressure and heart rate have low sensitivity for detecting early shock, meaning a patient can be in real trouble while those numbers remain in the normal range. That is why protocols that rely on a single snapshot of lactate and vital signs can miss a deteriorating patient. The body’s compensatory mechanisms, like vasoconstriction and increased heart rate, buy time but eventually fail, sometimes abruptly.

Clinical Signs That Help When Lactate Is Not Elevated

If a normal lactate cannot rule out serious sepsis, what should clinicians and patients pay attention to? Bedside physical exam findings gain importance when the usual biomarker alarm does not sound.

Capillary refill time, measured by pressing on a fingernail and timing how long color takes to return, is one of the simplest and most accessible perfusion checks. It reflects how well blood is flowing through the smallest vessels. Prolonged capillary refill suggests that the body is redirecting blood away from the periphery and toward vital organs, a classic early sign of shock.¹² It requires no lab equipment and can be performed at any level of care.

Capillary refill has even been tested head-to-head against lactate as a resuscitation target. A randomized trial comparing fluid resuscitation guided by capillary refill time versus lactate clearance found that both approaches resulted in similar regional, microcirculatory, and hypoxia-related perfusion outcomes by the end of the intervention period.¹³ In fact, some evidence suggests that targeting capillary refill time may avoid the excess fluid that lactate-guided strategies can produce, a point discussed further below.

Other clinical signs that deserve close attention in the setting of suspected sepsis with normal lactate include altered mental status (confusion, agitation, or unusual sleepiness), reduced urine output, skin mottling on the knees or extremities, and a temperature that is abnormally low rather than high. A hypothermic infection is often a worse prognostic sign than a fever. Data on sepsis outcomes by infection source found that a temperature below 38°C was associated with worse outcomes in community-acquired pneumonia and primary bloodstream infections.¹⁴

Why Serial Lactate Measurements Matter More Than a Single Reading

A single normal lactate at presentation is a snapshot. Sepsis is a dynamic process, and lactate can change significantly over hours. Serial measurements capture the trajectory, and the trend may be more informative than the starting point.

In patients who start with elevated lactate, the rate at which lactate falls after treatment, called lactate clearance, is one of the strongest predictors of survival. A study of pediatric septic shock found that failure to achieve at least a 10% reduction in lactate within 24 hours had a sensitivity of about 79% and specificity of about 72% for death.¹⁵ In adults with initial hyperlactatemia, the lactate level at six hours outperformed both the initial lactate and the calculated clearance rate for predicting 30-day mortality.¹⁶

But what about patients who start with a normal lactate? Recent research suggests serial measurements still add prognostic value in this group. A patient who initially presents with a normal reading but whose lactate drifts upward over the next several hours may be declaring a worsening picture that a one-time measurement would have missed entirely.¹⁷ This is the strongest argument against treating a normal initial lactate as the end of the conversation. It should be the beginning of monitoring, not a reason to stop.

The Problem With Lactate-Guided Fluid Resuscitation

Sepsis treatment bundles have traditionally called for aggressive fluid resuscitation and then titrating that fluid to lactate clearance. The idea is to keep giving fluids until lactate normalizes, on the theory that a falling lactate means tissue perfusion is improving. The trouble is that elevated lactate does not always mean the patient needs more fluid. Lactate can be high because of mitochondrial dysfunction, adrenergic stimulation, medication effects, or impaired liver clearance, none of which respond to additional intravenous fluid.

When clinicians chase lactate clearance with fluids in a patient whose lactate is high for non-fluid-responsive reasons, the result can be volume overload: swollen lungs, worsening oxygenation, and prolonged ICU stays. A review of the evidence found that titrating resuscitation to lactate clearance can lead to unnecessary fluid administration, and pointed to a randomized trial showing no benefit and potential harm with lactate-guided therapy compared to capillary refill time-guided therapy.¹⁸ This does not mean lactate measurement is useless. It means using lactate as the sole steering wheel for fluid decisions has real downsides.

Liver Disease Complicates Lactate Interpretation in Both Directions

The liver is responsible for clearing a large share of the lactate produced by the body. When liver function is compromised, lactate accumulates faster and clears more slowly, inflating the number independent of sepsis severity. In patients with cirrhosis and sepsis, lactate levels are significantly higher than in non-cirrhotic sepsis patients, even among survivors.¹⁹ And the problem gets worse with more advanced liver disease.

Lactate normalization, the point at which levels return to the normal range after treatment, is also harder for cirrhotic patients to achieve. In a cohort study, only about 8% of patients with cirrhosis achieved lactate normalization during sepsis treatment, compared to 37% of patients without liver disease.²⁰ Lactate clearance was also lower in the cirrhosis group. This means a persistently elevated lactate in a cirrhotic patient may reflect impaired clearance rather than ongoing tissue hypoperfusion, making it an unreliable guide for escalating treatment.

At the same time, lactate still has prognostic value in cirrhosis. Admission lactate levels above 4 mmol/L were associated with roughly four times higher odds of in-hospital mortality in patients with cirrhosis, similar to the risk increase seen in patients without cirrhosis.²¹ So the number still means something, but interpreting the trajectory is harder because the baseline is shifted upward and the clearance machinery is impaired.

Age-Related Differences in Lactate Response

Older adults who die from sepsis tend to have lower peak lactate levels than younger patients who die from sepsis. One study found that elderly non-survivors had lactate levels roughly 1 mmol/L lower than non-elderly non-survivors. Both groups still showed that lactate above 4 mmol/L carried dramatically higher adjusted odds of mortality (about five-fold for elderly patients and nearly six-fold for non-elderly patients, compared to those with lactate below 2 mmol/L).²²

The practical implication is that using a single fixed lactate cutoff across all age groups may systematically under-triage older patients. A 78-year-old with a lactate of 3.5 mmol/L may be in worse shape than a 45-year-old with the same reading, because the older patient’s body is less capable of generating the adrenergic surge that drives lactate upward. This is especially relevant given that older adults already have higher baseline mortality from infection and may present with subtler symptoms like confusion rather than the obvious fevers and fast heart rates that trigger rapid sepsis protocols.

Other Biomarkers and Combination Approaches

Lactate is not the only game in town. Procalcitonin, a protein that rises in bacterial infections, outperformed lactate slightly in predicting positive blood cultures in one emergency department study, with both significantly outperforming C-reactive protein. Combining procalcitonin and lactate together improved prediction further.²³ Neither marker alone is a perfect diagnostic test, but using them together helps compensate for each marker’s blind spots.

Central venous oxygen saturation, measured from a catheter in a large vein near the heart, offers another window into whether tissues are extracting oxygen normally. One study found that a widened gap between carbon dioxide levels in venous and arterial blood was associated with higher mortality in septic patients, but only within a specific oxygen saturation range.²⁴ These markers require invasive monitoring and are typically only available in ICU settings, but they illustrate the broader principle: no single number captures the full picture of sepsis physiology. A combined biomarker approach has shown promise in predicting 28-day mortality, outperforming organ dysfunction scores used alone.²⁵

Why Antibiotic Timing Matters Regardless of Lactate

Perhaps the most important takeaway for anyone involved in sepsis care, whether as a clinician, a patient, or a family member advocating at the bedside, is that prompt antibiotic administration matters regardless of what the lactate level says. A study analyzing delays from first medical contact to antibiotic administration found that each hour of delay in the emergency department was independently associated with a small but meaningful increase in the odds of in-hospital death.²⁶

In the study of sepsis patients with normal lactate and hypotension discussed earlier, the two factors most strongly associated with in-hospital mortality were failure to use appropriate antibiotics and delayed lactate measurement.⁹ Not the blood pressure. Not the lactate level itself. The actions taken, and how quickly. The lactate value is a piece of information, not a treatment decision. When sepsis is suspected, the clock starts ticking whether the lactate is 1.2 or 12.